Search details
1.
A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens.
BMC Cancer
; 24(1): 121, 2024 Jan 24.
Article
in English
| MEDLINE | ID: mdl-38267903
2.
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
J Natl Compr Canc Netw
; : 1-9, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38744306
3.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37387213
4.
Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma.
Breast Cancer Res
; 25(1): 11, 2023 01 27.
Article
in English
| MEDLINE | ID: mdl-36707876
5.
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 201(3): 377-385, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37344660
6.
Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices.
Oncologist
; 27(12): 1008-1015, 2022 12 09.
Article
in English
| MEDLINE | ID: mdl-36215276
7.
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
N Engl J Med
; 380(20): 1929-1940, 2019 05 16.
Article
in English
| MEDLINE | ID: mdl-31091374
8.
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med
; 381(4): 307-316, 2019 07 25.
Article
in English
| MEDLINE | ID: mdl-31166679
9.
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients.
Breast Cancer Res Treat
; 192(3): 629-637, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35113257
10.
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
BMC Med
; 20(1): 105, 2022 03 17.
Article
in English
| MEDLINE | ID: mdl-35296300
11.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-33451345
12.
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.
Breast Cancer Res Treat
; 189(3): 665-676, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34553296
13.
Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women.
Oncologist
; 25(2): e252-e258, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32043784
14.
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations.
Oncologist
; 25(1): e16-e23, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31371522
15.
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
J Neurooncol
; 148(1): 165-172, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32346837
16.
Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.
Breast Cancer Res Treat
; 177(3): 549-559, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31270763
17.
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer.
Future Oncol
; 15(21): 2489-2501, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31140297
18.
PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study.
J Formos Med Assoc
; 118(9): 1333-1338, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-30577988
19.
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Lancet Oncol
; 19(7): 904-915, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29804902
20.
Association of pregnancy and mortality in women diagnosed with breast cancer: A Nationwide Population Based Study in Taiwan.
Int J Cancer
; 143(10): 2416-2424, 2018 11 15.
Article
in English
| MEDLINE | ID: mdl-30070358